Michael T. Flavin

3.4k total citations
48 papers, 2.1k citations indexed

About

Michael T. Flavin is a scholar working on Infectious Diseases, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Michael T. Flavin has authored 48 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 21 papers in Molecular Biology and 19 papers in Organic Chemistry. Recurrent topics in Michael T. Flavin's work include HIV/AIDS drug development and treatment (18 papers), Carbohydrate Chemistry and Synthesis (12 papers) and Natural product bioactivities and synthesis (9 papers). Michael T. Flavin is often cited by papers focused on HIV/AIDS drug development and treatment (18 papers), Carbohydrate Chemistry and Synthesis (12 papers) and Natural product bioactivities and synthesis (9 papers). Michael T. Flavin collaborates with scholars based in United States, Taiwan and Spain. Michael T. Flavin's co-authors include Ze‐Qi Xu, Yuh‐Meei Lin, Fa‐Ching Chen, Yasheen Zhou, Liming Zhou, Albert Khilevich, Eugenia Mata‐Greenwood, Stephen H. Hughes, John M. Pezzuto and Thitima Pengsuparp and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Michael T. Flavin

48 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael T. Flavin United States 21 995 795 405 317 294 48 2.1k
Keduo Qian United States 32 895 0.9× 1.6k 2.0× 298 0.7× 310 1.0× 349 1.2× 74 2.7k
Babu L. Tekwani United States 31 784 0.8× 995 1.3× 273 0.7× 351 1.1× 210 0.7× 98 2.5k
Mark Cushman United States 35 1.3k 1.4× 1.8k 2.3× 463 1.1× 106 0.3× 466 1.6× 120 3.5k
Jane X. Kelly United States 23 685 0.7× 787 1.0× 320 0.8× 215 0.7× 327 1.1× 40 2.5k
Silvia Parapini Italy 30 964 1.0× 728 0.9× 208 0.5× 193 0.6× 239 0.8× 113 2.7k
Naheed Mahmood United Kingdom 22 492 0.5× 975 1.2× 267 0.7× 493 1.6× 398 1.4× 62 2.1k
Sankaranarayanan Murugesan India 32 1.7k 1.7× 1.1k 1.4× 332 0.8× 202 0.6× 307 1.0× 204 3.4k
Li Huang United States 34 808 0.8× 1.3k 1.6× 294 0.7× 224 0.7× 569 1.9× 100 2.8k
Elizabeth A. Gullen United States 24 450 0.5× 713 0.9× 151 0.4× 184 0.6× 406 1.4× 51 1.6k
Lan Xie China 26 1.2k 1.2× 629 0.8× 262 0.6× 144 0.5× 448 1.5× 83 2.1k

Countries citing papers authored by Michael T. Flavin

Since Specialization
Citations

This map shows the geographic impact of Michael T. Flavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Flavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Flavin more than expected).

Fields of papers citing papers by Michael T. Flavin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael T. Flavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Flavin. The network helps show where Michael T. Flavin may publish in the future.

Co-authorship network of co-authors of Michael T. Flavin

This figure shows the co-authorship network connecting the top 25 collaborators of Michael T. Flavin. A scholar is included among the top collaborators of Michael T. Flavin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael T. Flavin. Michael T. Flavin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaja, Simon, et al.. (2024). Safety and tolerability of pooled human immune globulins after topical ophthalmic administration in New Zealand White rabbits. Cutaneous and Ocular Toxicology. 43(3). 227–231. 1 indexed citations
2.
Marlowe, Timothy, et al.. (2019). High resolution crystal structure of the FAK FERM domain reveals new insights on the Druggability of tyrosine 397 and the Src SH3 binding site. BMC Molecular and Cell Biology. 20(1). 10–10. 14 indexed citations
3.
Dementiev, Alexey, Calvin Yee, Zhe Li, et al.. (2018). Structures of human plasma β–factor XIIa cocrystallized with potent inhibitors. Blood Advances. 2(5). 549–558. 44 indexed citations
4.
Gelhaus, H. Carl, Michael S. Anderson, David A. Fisher, et al.. (2013). Efficacy of Post Exposure Administration of Doxycycline in a Murine Model of Inhalational Melioidosis. Scientific Reports. 3(1). 1146–1146. 13 indexed citations
5.
Xu, Ze‐Qi, et al.. (2013). Combating multidrug-resistant Gram-negative bacterial infections. Expert Opinion on Investigational Drugs. 23(2). 163–182. 110 indexed citations
6.
Zembower, David E., Mary J. Kuffel, Matthew M. Ames, et al.. (2012). Methylenedioxy- and Ethylenedioxy-Fused Indolocarbazoles: Potent Human Topoisomerase I Inhibitors and Antitumor Agents. Anti-Cancer Agents in Medicinal Chemistry. 12(9). 1117–1131. 8 indexed citations
7.
Flavin, William P., et al.. (2010). Synthesis, proapoptotic screening, and structure–activity relationships of novel aza-lupane triterpenoids. Bioorganic & Medicinal Chemistry Letters. 20(18). 5389–5393. 9 indexed citations
8.
Xu, Ze‐Qi, et al.. (2006). Pyranocoumarin, a novel anti-TB pharmacophore: Synthesis and biological evaluation against Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry. 14(13). 4610–4626. 87 indexed citations
9.
Eiznhamer, David, et al.. (2004). Effective attenuation of endotoxin-induced acute lung injury by 2,3-diacetyloxybenzoic acid in two independent animal models. Pulmonary Pharmacology & Therapeutics. 17(2). 105–110. 7 indexed citations
10.
Xu, Ze‐Qi, William W. Barrow, William J. Suling, et al.. (2004). Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry. 12(5). 1199–1207. 81 indexed citations
11.
Lin, Yuh‐Meei, et al.. (2002). Chalcones and flavonoids as anti-Tuberculosis agents. Bioorganic & Medicinal Chemistry. 10(8). 2795–2802. 411 indexed citations
12.
Raffen, Rosemarie, et al.. (2001). Amyloid fibril formation in microwell plates for screening of inhibitors. Amyloid. 8(3). 182–193. 10 indexed citations
13.
Lin, Yuh‐Meei, et al.. (2001). Biflavonoids as novel antituberculosis agents. Bioorganic & Medicinal Chemistry Letters. 11(16). 2101–2104. 63 indexed citations
14.
Xu, Ze‐Qi, et al.. (2000). Quantification of (+)-calanolide A, a novel and naturally occurring anti-HIV agent, by high-performance liquid chromatography in plasma from rat, dog and human. Journal of Chromatography B Biomedical Sciences and Applications. 742(2). 267–275. 6 indexed citations
15.
Buckheit, Robert W., et al.. (2000). Anti-HIV-1 Activity of Calanolides Used in Combination with other Mechanistically Diverse Inhibitors of HIV-1 Replication. Antiviral chemistry & chemotherapy. 11(5). 321–327. 16 indexed citations
16.
Flavin, Michael T., et al.. (1999). Antiviral Activities of Biflavonoids. Planta Medica. 65(2). 120–125. 168 indexed citations
17.
Xu, Ze‐Qi, et al.. (1999). In vivo anti-HIV activity of (+)-calanolide a in the hollow fiber mouse model. Bioorganic & Medicinal Chemistry Letters. 9(2). 133–138. 45 indexed citations
18.
Zembower, David E., Yuh‐Meei Lin, Michael T. Flavin, Fa‐Ching Chen, & Brent E. Korba. (1998). Robustaflavone, a potential non-nucleoside anti-hepatitis B agent. Antiviral Research. 39(2). 81–88. 51 indexed citations
19.
Xu, Ze‐Qi, Robert W. Buckheit, Michael T. Flavin, et al.. (1998). In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI. Bioorganic & Medicinal Chemistry Letters. 8(16). 2179–2184. 40 indexed citations
20.
Lin, Yuh‐Meei, Michael T. Flavin, Eugenia Mata‐Greenwood, et al.. (1997). In Vitro Anti-HIV Activity of Biflavonoids Isolated fromRhus succedaneaandGarcinia multiflora. Journal of Natural Products. 60(9). 884–888. 225 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keduo Qian Breakdown of academic impact, for papers by Babu L. Tekwani Breakdown of academic impact, for papers by Mark Cushman Breakdown of academic impact, for papers by Jane X. Kelly Breakdown of academic impact, for papers by Silvia Parapini Breakdown of academic impact, for papers by Naheed Mahmood Breakdown of academic impact, for papers by Sankaranarayanan Murugesan Breakdown of academic impact, for papers by Li Huang Breakdown of academic impact, for papers by Elizabeth A. Gullen Breakdown of academic impact, for papers by Lan Xie
Rankless by CCL
2026